Emmaus Life Sciences (EMMA) Equity Income (2019 - 2023)
Emmaus Life Sciences' Equity Income came in at -$366,000 for Q4 2023, compared with -$423,000 a year earlier.
Powered by 
Analysis
Emmaus Life Sciences (EMMA) Equity Income (2019 - 2023) Analysis & Trends
For FY2023, Emmaus Life Sciences' Equity Income was -$1.71 million.
- Going back by year, Equity Income was -$1.91 million in FY2022, -$2.73 million in FY2021, -$2.06 million in FY2020 and -$414,000 in FY2019.
- The Q4 2023 figure represents the highest quarterly Equity Income since Q4 2019.
- Business Quant data shows EMMA's Equity Income at -$381,000 (Q3 2023), -$439,000 (Q2 2023) and -$527,000 (Q1 2023) in the three quarters before Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | -2.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | -10.00 Mn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Emmaus Life Sciences | 3.51 Mn | -2.79 Mn | 5.97 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -366,000.00 |
| Sep 30, 2023 | -381,000.00 |
| Jun 30, 2023 | -439,000.00 |
| Mar 31, 2023 | -527,000.00 |
| Dec 31, 2022 | -423,000.00 |
| Sep 30, 2022 | -431,000.00 |
| Jun 30, 2022 | -493,000.00 |
| Mar 31, 2022 | -566,000.00 |
| Dec 31, 2021 | -734,000.00 |
| Sep 30, 2021 | -663,000.00 |
| Jun 30, 2021 | -582,000.00 |
| Mar 31, 2021 | -754,000.00 |
| Dec 31, 2020 | -586,000.00 |
| Sep 30, 2020 | -494,000.00 |
| Jun 30, 2020 | -573,000.00 |
| Mar 31, 2020 | -407,000.00 |
| Dec 31, 2019 | -1,000.00 |
| Sep 30, 2019 | 36,000.00 |
| Jun 30, 2019 | -458,000.00 |
| Mar 31, 2019 | 9,000.00 |
API Access
Emmaus Life Sciences Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=EMMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();